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Collisionally activated decompositions (CAD) of [M1H]1 ions from two sets (estrone and
estradiol) of three isomeric glutathione (GSH) conjugates were studied by using five tandem
mass spectrometric methods: (1) low energy (LE) CAD in an ion trap, (2) LE CAD in a triple
quadrupole, (3) electrospray ionization (ESI)-source CAD in a tandem four sector, (4) high
energy (HE) CAD of both ESI-produced and fast-atom bombardment (FAB)-produced ions in
a tandem four-sector mass spectrometer, and (5) metastable-ion decompositions of FAB-
produced ions. Four types of fragment ions are produced. The first type, formed from cleavage
of the peptide backbone, gives rise to modified b2, modified y2, y2, and b1 ions. These
fragments are observed with all the methods and show that the catechol estrogen attachment
is at the cysteine moiety of the GSH. Internal fragment ions are the second type, and they also
support that the modification is at cysteine. The third type involves fragmentation of the C–S
bond to give an ion containing the steroid bonded to the sulfur. The fourth type of fragment
ion is similar to the third but involves oxidation of the steroid ring and reduction of the GSH
moiety; it is the most isomer specific of the four. The isomer-specific ions are of relatively low
abundance in the product-ion spectra taken on the triple quadrupole and ion trap, but their
abundances can be improved by increasing the collision energy. ESI source-CAD and the
HE-CAD spectra of the isomers are the most distinctive because abundant product ions of all
four types are seen in a single spectrum. (J Am Soc Mass Spectrom 1998, 9, 612–619) © 1998
American Society for Mass Spectrometry
Endogenous steroid hormones, estrone (E1) and17b-estradiol (E2), are metabolized via two majorpathways: 2- and 4-hydroxylation to form cate-
chol estrogens (CE) and 16a-hydroxylation [1, 2]. The
CE metabolites are usually methylated by catechol-O-
methyltransferases (COMT) or conjugated to form glu-
curonides and sulfates. All these pathways serve to
prevent oxidation of CE to reactive electrophilic qui-
nones. When the level of CE is elevated and/or the
activity of conjugating enzymes is decreased, CE accu-
mulate and can be further oxidized by peroxidases or
cytochrome P450 to form CE quinones. The quinones
are electrophilic and are susceptible to adduction, via
Michael addition, to the nucleophilic groups of cellular
macromolecules [3–5] and glutathione (GSH) [6]. Bind-
ing of CE quinones to DNA can lead to carcinogenesis
[5], whereas binding to GSH leads to excretion [6].
Adduction to the tripeptide glutathione (g-glutamyl-
L-cystenylglycine), which occurs in all living cells [6],
and most abundantly in the liver cells, is one of the
major excretory pathways for many structurally diverse
substrates ranging from xenobiotics [7] to toxic metals
[8]. In most cells, the GSH concentration is in the range
of 0.1 to 10 mM, and the body maintains the ratio
between the oxidized (GS-SG) and the reduced (GSH)
forms as low as 0.1 [9], facilitating the conjugation of the
reduced GSH by glutathione-S-transferases (GST) to
exogenous and endogenous electrophiles [10].
Conjugation to GSH and adduction to DNA involve
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similar chemistry. Because adduct formation is a re-
quired early step in tumor initiation, the detection and
characterization of estrogen-DNA adducts in target
tissues is important for understanding carcinogenesis
and for estimating risk. But detection and characteriza-
tion of an estrogen-DNA adduct are difficult because
only one base in 106–108 is modified. On the other hand,
quinones readily react with GSH to give more abundant
and easily measured adducts. Mass spectrometry, in
combination with tandem mass spectrometry, has been
used to determine a variety of GSH conjugates [11–14],
including those from in vitro and in vivo experiments
[15]; a preliminary announcement of this work was
made [16].
In the research reported in this article, we have taken
the challenge of determining isomeric GSH adducts of
estrone and estradiol. We compare the results from four
tandem mass spectrometric methods in which MS/MS
experiments only were conducted and from ESI-source
CAD. The outcome of the first two methods is an
LE-CAD spectrum of product ions from ESI-produced
[M1H]1 ions; the product ions were formed in either
an ion trap (method 1) or a triple-quadrupole mass
spectrometer (method 2). Method 3 gives ESI-source
CAD spectra, and method 4 produces an HE CAD
spectrum of either ESI or FAB-produced ions; methods
3 and 4 utilize a tandem four-sector mass spectrometer.
The outcome of method 5 is a metastable-ion (MI)
spectrum from the four-sector instrument. The focus of
the article is the evaluation of mass spectrometric
methods for distinguishing structural isomers of cate-
chol estrogen-GSH (CE-GSH) conjugates; we chose not
to evaluate other analytical issues (limits of detection
and quantification, linearity of calibration, etc.) even
though we were able to obtain product-ion spectra, in
some cases, of femtomole quantities of adducts.
Experimental
Materials
The conjugates were prepared by mixing the corre-
sponding quinones in acetonitrile with a 50/50 water/
acetic acid solution of GSH [17]. UV, NMR, exact-mass
measurements, and tandem mass spectrometry (MS/
MS) were used to confirm the structures of the GSH
conjugates of estrone and estradiol. Synthesis and con-
firmation of these conjugates were described in a sepa-
rate article [17].
Mass Spectrometry
The first set of LE-CAD spectra were acquired by using
a Finnigan (Finnigan MAT, San Jose, CA, USA) quad-
rupole ion trap (LCQ) equipped with a Finnigan ESI
source. Samples were dissolved in 50/49/1 methanol/
water/acetic acid to give a final concentration of 5
pmol/mL and were introduced via a 5-mL loop injector
into a 10-mL/min flow of 50/49/1 methanol/water/
acetic acid. Although the detection limit for modified
GSH conjugates was approximately 25 fmol, a higher
concentration was used to insure that the tandem mass
spectra had a good signal-to-noise ratio. The spray
needle was held at 4.2 kV, and 4.8 3 105 Pa coaxial flow
of nitrogen was used to stabilize the spray. A heated
(200 °C) stainless steel capillary held at 5 V served as a
counter electrode. Helium was introduced to a pressure
of 1 mtorr for improving the trapping efficiency of the
ion trap (background pressure of 2.7 3 1023 Pa) and for
use as the collision gas during the CAD event. Ions
were detected by a 15-kV conversion dynode interfaced
to a channeltron electron multiplier.
The second set of LE-CAD experiments was carried
out with a Finnigan TSQ 7000 triple quadrupole mass
spectrometer, which was equipped with a Finnigan ESI
source similar to that of the LCQ. The electrospray
needle was held at 5000 V, and the counter electrode, a
heated stainless steel capillary, was held at 5 V. Samples
were dissolved in 50/49/1 methanol/water/acetic acid
to give a final concentration of 50 pmol/mL and were
loop injected into a 5-mL/min flow of the same solvent.
The detection limit for steroid-modified GSH with the
triple quadrupole is in the range of 5 to 50 fmol, but a
higher concentration was used so that high quality
tandem mass spectra could be obtained. For all MS/MS
experiments, argon was used as collision gas at a
pressure of approximately 0.33 Pa. For obtaining the
breakdown graphs, the collision energy was varied
from 20 to 60 eV by changing the offset voltage of Q2
with respect to that of Q1. For comparison of product-
ion spectra, a collision energy of 25 eV was chosen.
ESI source-CAD, HE-CAD, and MI spectra of prod-
uct ions were obtained by using a VG ZAB-T (Manches-
ter, UK) four-sector tandem mass spectrometer [18]
equipped with a VG ESI source. The ESI needle was at
8000 V and the counter electrode (“pepper pot”) at 5000
V. To induce CAD in the high-pressure region between
the sampling cone and the skimmer, the sampling cone
potential was increased to approximately 135 V above
the optimal operating potential of 4177 V. Skimmer
lens, skimmer, ring electrode, and hexapole were typi-
cally held at 4125, 4120, 4115, and 4115 V, respectively.
Nitrogen was used as bath and nebulizer gas with a
flow rate of 400 and 12 L/h, respectively. Samples (50
pmol/mL), dissolved in 50/49/1 methanol/water/ace-
tic acid, were injected into the flow of a similar solvent
system via a six port Rheodyne 7125 injector with a
20-mL external loop. A Harvard model 22 syringe pump
was used to infuse the solvent at a flow rate of 10
mL/min.
For FAB, samples were dissolved in 50/50 water/
methanol to give a final concentration of 2 nmol/mL. A
1-mL aliquot was loaded on the probe along with 1 mL
of glycerol with 1% trifluroacetic acid (GLY/TFA). A
Cs1 ion gun operated at 30 kV was used to desorb the
ions, which were accelerated to 18.0 keV.
HE CAD mass spectra of ESI-produced ions were
obtained after precursor-ion activation in the third
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field-free region (between MS1 and MS2). Sufficient
helium was added to the collision cell, which was
floated at 2 kV, to attenuate the ion beam by 80%. The
first (MS1) and second-stage (MS2) mass spectrometers
were operated at resolving powers of 1000 and 800 (full
width at half-height definition), respectively. To obtain
high-energy CAD spectra of FAB-produced ions, the
collision cell was floated at 4 kV, and sufficient helium
was introduced into the cell to attenuate the ion beam
by 50%. Ten to fifteen 15-s scans were signal-averaged
for each spectrum. The metastable-ion decompositions
of FAB-produced ions were followed under the same
conditions as the HE CAD experiments, but no collision
gas was introduced into the collision cell. All MI and
CAD spectra were acquired by using a VG (Manchester,
UK) data system equipped with a DEC Alpha 3000
work station, OPUS V 3.1X software, and a VG SIOS I
interface.
Nomenclature
When referring to both E1 and E2 catechols, we will use
the term CE. The terms E1-GSH and E2-GSH are used to
refer to all isomers of estrone and estradiol, respec-
tively. The nomenclature proposed by Roepstorff and
Fohlman, as modified by Biemann [19], was used to
describe the peptide backbone fragmentation of the
GSH moiety. All GSH fragment ions containing cate-
chol estrogen moiety, Rx, are referred to as modified
backbone fragment ions. Internal fragment ions are
described by the nomenclature of Gaskell and co-
workers [20].
Results and Discussion
In this study, we evaluate the effectiveness of five
tandem mass spectrometric methods to characterize
two sets of isomeric CE-modified GSH conjugates. One
set consists of three isomers of estrone conjugates, and
the second is represented by three isomers of estradiol
conjugates (see Figures 1 and 2 for structures and
abbreviations).
Low-Energy CAD Spectra of ESI-Produced Ions on
an Ion Trap
To establish a reference point, we discuss briefly the LE
CAD of GSH (g-glu-cys-gly) itself. ESI of GSH gives
[M1H]1 and [M1Na]1 ions of m/z 308 and 330,
respectively. LE CAD of the [M1H]1 ions gives the
expected z2, y2, and b2 ions of m/z 162, 179, and 233.
LE CAD product-ion spectra of the [M1H]1 ions
(m/z 592) of catechol E1-GSH conjugates 4-OHE1-2-SG,
2-OHE1-4-SG, and 2-OHE1-1-SG are nearly identical
(Figure 1). Similarly, the product-ion spectra of cate-
chol-E2-GSH [M1H]
1 ions of m/z 594 from 4-OHE2-2-
SG, 2-OHE2-4-SG, and 2-OHE2-1-SG are also very sim-
ilar (Figure 2). Peptide backbone fragmentations give
rise to modified b2, and y2 ions, which we designate as
Figure 1. Tandem mass spectra of ESI-produced [M1H]1 ions
from (A) 4-OHE1-2-SG, (B) 2-OHE1-4-SG, and (C) 2-OHE1-1-SG,
obtained by using an ion-trap mass spectrometer.
Figure 2. Tandem mass spectra of ESI-produced [M1H]1 ions
from (A) 4-OHE2-2-SG, (B) 2-OHE2-4-SG, and (C) 2-OHE2-1-SG,
obtained by using an ion-trap mass spectrometer.
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*b2 and *y2, suggesting that the Cys moiety has been
modified. We will refer to these and other product ions
from backbone cleavages as “type 1” (see Scheme I). For
E1 and E2 adducts, these fragment ions are at m/z 517
and 463 (Figure 1) and 519 and 465 (Figure 2), respec-
tively, and are consistent with those reported in earlier
studies of the LE CAD of GSH adducts [11–14]. Because
there is a low-mass cutoff for the ion trap, the comple-
mentary b1 and y1 fragment ions could not be observed.
Internal fragment ions of the structure 1NH2A
CHCH2S–Rx (Schemes I and II), where Rx, is either the
estrone or estradiol moiety are at m/z 360 (Figure 1)
and 362 (Figure 2). These fragment ions are common in
tandem mass spectra of GSH conjugates and are re-
ferred to as g ions, following the nomenclature pro-
posed by Gaskell and co-workers [20]. The same group
also suggested that the h fragment, 1CHA CH–S–Rx, is
formed by loss of ammonia from the g fragment ion. For
the purpose of organizing this article, we will call these
ions “type 2.”
For both sets of conjugates, the fragment ion of m/z
317 (E1) or 319 (E2) from the cleavage of the C–S bond is
the dominant product ion (Schemes I and III). This
fragmentation releases the steroid as an ion with the
sulfur attached. The m/z 317 and 319 ions subsequently
lose H2O to give the product ions of m/z 299 or 301,
respectively. These and the ions discussed next will be
called “type 3.”
The product ion of m/z 284 from E1-GSH conjugates
and 286 from E2-GSH conjugates is likely to result from
loss of an HS radical from the ions of m/z 317 or 319,
respectively. This loss of HS is analogous to that from
alkyl phenyl thioethers [21]. Loss of H2S from GSH
adducts was also observed previously [22] and may
account for the low-abundance product ions of m/z 283
and 285 from the m/z 317 (E1) and 319 (E2) ions,
respectively.
An interesting pair of ions are those of m/z 315 and
297 from the E1-GSH conjugates and 317 and 299 from
the E2-GSH conjugates; we will refer to these as “type
4.” These product ions are not detectable when the GSH
is attached at position 2 of the A ring of the steroid,
barely detectable when the attachment is at position 4,
and definitely detectable when the attachment is at
position 1. Although neither fragment is of high abun-
dance in the ion-trap, product-ion spectra, they assume
considerably more importance in ESI-source CAD and
HE CAD spectra, which will be discussed later.
Although the ion-trap spectra strongly suggest that
Cys is modified by the steroid, the inability to observe
b1, y1 in an MS/MS experiment and the relatively low
abundances of the y2 and type-4 fragment ions make the
identification of isomeric GSH conjugates difficult
when using only one stage of MS/MS.
CAD of ESI-Produced Ions in a Triple Quadrupole
To evaluate triple quadrupole mass spectrometers for
distinguishing these structural isomers and to assess if
there is additional information for distinguishing iso-
mers in the lower mass region of the tandem mass
Scheme I. Four types of fragment ions observed with CE-GSH
conjugates.
Scheme II. Proposed mechanism for formation of internal frag-
ment ions.
Scheme III. Proposed mechanism for formation of ion of m/z 317
and 299 and 319 and 301 from GSH conjugates of E1 and E2,
respectively.
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spectra, we investigated the same set of conjugates with
this instrumentation.
Energy-resolved CAD spectra. Energy-resolved spectra
were obtained by systematically varying the collision
energy and obtaining product-ion abundances as a
function of that energy. Breakdown graphs for 4-OHE2-
2-SG (Figure 3A) and 2-OHE2-1-SG (Figure 3B) show
that the *y2 of m/z 465 and the m/z 519 and 319 ions are
primary fragments. With increasing collision energy in
the range of 10–45 eV, the ion of m/z 465 fragments in
part to form the ion of m/z 319. Increasing the collision
energy above 35 eV causes the abundances of the
isomer-specific fragment ions (m/z 317, 299, and 286)
and the low-mass fragment ions from the GSH moiety
(m/z 130, 179, 177, 205, and 207) to grow at the expense
of the higher mass-to-charge ratio (.345) fragment ions
(some of these fragments are not shown in the figure to
minimize congestion). The breakdown graphs clearly
show isomeric differences; for 2-OHE2-1-SG, the m/z
317 and 299 (type-4 ions) become the important second-
and third-generation products, whereas they are not
detectable for 4-OHE2-2-SG.
The breakdown graphs clearly show that the choice
of collision energy is critical for distinguishing the
spectra of the isomers. Because the four types of frag-
ment ions can be seen at 25 eV, we chose that energy to
compare tandem mass spectra of the six isomers.
LE CAD of CE-GSH adducts. At 25-eV collision energy,
both sets of three isomers fragment most readily by C–S
bond cleavage (spectra not given). The peptide-back-
bone fragmentation gives the *y2 and *b2 fragment ions
at m/z 517 and 463, respectively. The type-2 product
ions of m/z 360 and 343, which are 1NH2A
CHCH2S–Rx and
1CHACH–S–Rx, respectively, are rel-
atively less abundant in the spectrum of 4-OHE1-2-SG,
than in the spectra of the other two isomers. This trend
also follows that obtained when using the ion trap.
The product ions of m/z 317 (E1 adducts) or 319 (E2
adducts) are most abundant. Differences pertain for the
m/z 315 ion, which is absent in the spectrum of
4-OHE1-2-SG, of modest abundance in that of 2-OHE1-
4-SG, and relatively more abundant in that of 2-OHE1-
1-SG. The fragment ion of m/z 297, formed from loss of
a water molecule from the ion of m/z 315, is absent in
the spectra of 4-OHE1-2-SG and present at modest and
high abundance in the spectra of 2-OHE1-4-SG and
2-OHE1-1-SG, respectively. An analogous situation ap-
plies to the m/z 317 and 299 ion from the E2 isomers.
These two pairs of product ions (i.e., of m/z 315/297
and 317/299) are most important for distinguishing
isomers.
Fragment ions of m/z 284 formed by loss of an HS
radical from the m/z 317 ion, are also isomer specific.
They are readily detectable from 4-OHE1-2-SG, mod-
estly abundant from 2-OHE1-4-SG, and barely detect-
able from 2-OHE1-1-SG, an order that is opposite those
for the m/z 315 and 297 ions. The corresponding
fragments for the estradiol conjugates shift upward by
2 u, but the trends for dissociation are similar to those
for the E1 conjugates. Although we do not understand
the reason for these trends, we note that the breakdown
curves (Figure 3) show that the m/z 286 ion is the
important terminal fragment for 4-OHE2-2-SG, whereas
the m/z 299 ion plays the same role for 2-OHE2-1-SG.
Some low-mass fragment ions are also useful for
distinguishing the isomers, but it is difficult to rational-
ize the trends. The unmodified b1 ion of m/z 130 is one
example (it is likely that this ion is a fragment of *b1).
Figure 3. Breakdown graph of ESI-produced [M1H]1 ions from (A) 4-OHE2-2-SG and (B) 2-OHE2-
1-SG, obtained using a triple-quadrupole mass spectrometer.
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Loss of 129 u from GSH conjugates is one process that
has been used in constant-neutral loss scanning to
detect GSH conjugates from in vivo experiments [15].
Although establishing the expected attachment of CE
to Cys is relatively simple using low-mass product ions,
assigning a spectrum to a specific isomer is difficult.
Results with the triple quadrupole, which are similar to
those obtained with the ion trap, provide some evi-
dence to distinguish the isomers. For example, although
the fragment ions of m/z 315/317 and 297/299 are not
clear evidence in the 25-eV spectra of 2-CE-4-SG, in-
creasing the collision energy enhances the abundance of
these fragments but at the expense of the high-mass
fragments. Clearly an integrated view of the energy-
dependent fragmentation is needed to distinguish the
isomers because no single LE CAD can provide a
complete identification. The breakdown curves serve
that function, but they require time and sample to
generate. These limitations of LE CAD spectra
prompted us to study these adducts by using ESI-
source CAD and HE CAD on a tandem four-sector mass
spectrometer.
ESI-Source CAD in a Sector Mass Spectrometer
Although ESI-source CAD requires introduction of
pure samples into the mass spectrometer, it can have,
when conducted on a magnetic sector mass spectrom-
eter, relatively high-mass resolving power. ESI of E1
conjugates yields dominant [M1H]1 (m/z 592) and
negligible [M1Na]1 (m/z 614). Similarly, ESI of E2
conjugates also yields abundant [M1H]1 and some
[M1Na]1. Increasing the sampling cone potential by
135 V above the optimal value causes dissociation in the
high-pressure region between the sampling cone and
the skimmer, giving spectra (Figure 4) that are similar to
those from the ion trap and the triple quadrupole except
the isomerically distinctive m/z 284 and type-4 ions are
more apparent. The type-4 fragments are barely detect-
able in the spectra of 4-OHE1-2-SG and 4-OHE2-2-SG,
whereas for 2-OHE1-4-SG and 2-OHE2-4-SG, they are
quite abundant and even more abundant for 2-OHE1-
1-SG and 2-OHE2-1-SG. Some key low-mass fragments,
b1, a2, and y2 ions, are present in all spectra, but they are
of low abundance. The unmodified a2 and y2 ions are
presumably products of the corresponding modified
species. Nevertheless, unambiguous assignments of the
three E1 and E2 isomers are possible with the mass
spectra from this method.
High-Energy CAD Spectra
The success in distinguishing isomers achieved by
using ESI-source CAD provided additional incentive to
test HE CAD for distinguishing the isomeric GSH
adducts of E1 and E2. We chose to produce the precur-
sor ions by both ESI and FAB.
ESI-produced ions. In contrast to LE-CAD spectra,
abundant isomer-specific ions (type 4 and m/z 284/
286) as well as types 1–3 fragment ions are observed in
HE CAD spectra (Figure 5). The important distinguish-
Figure 4. ESI-source CAD of ions from (A) 4-OHE1-2-SG, (B)
2-OHE1-4-SG, and (C) 2-OHE1-1-SG, obtained by using a tandem
four-sector mass spectrometer.
Figure 5. Tandem mass spectra of ESI-produced [M1H]1 ions
from (A) 4-OHE1-2-SG, (B) 2-OHE1-4-SG, and (C) 2-OHE1-1-SG,
obtained by using a tandem four-sector mass spectrometer.
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ing features for 4-OHE1-2-SG with respect to the other
isomers are the negligible abundances of the m/z 315
and 297 ions and the abundant m/z 284 ion. In the
spectrum of 2-OHE1-4-SG, the m/z 315 and 297 ions
make their appearance at modest abundance. For the
third isomer, 2-OHE1-1-SG, we see the highest abun-
dances for the m/z 315 and 297 ions and the lowest
abundances of the m/z 284 ion and the internal g ion of
m/z 360.
HE-CAD spectra from E2 conjugates, shown in Fig-
ure 6 are similar to those of E1 conjugates. All fragments
containing the steroid are observed, but their masses
are shifted by 2 u. Recalling that the key fragments for
distinguishing the isomers are of type 4 (m/z 317 and
299), and the m/z 286 ion, we note that the ions of m/z
317 and 299 are most abundant in the spectra of
2-OHE2-1-SG, not detectable in that of 4-OHE2-2-SG,
and intermediate in that of the 2-OHE2-4-SG; this trend
as the same as that for the E1 conjugates.
We propose as a mechanism for the type-4 ions that
oxidation of the steroid moiety occurs, involving trans-
fer of a favorable tertiary hydrogen (Schemes I and IV)
for 2-OHE1-1-SG and 2-OHE2-1-SG. For 2-OHE1-4-SG
and 2-OHE2-4-SG adducts, oxidation of the steroid
moiety involves transfer of a secondary hydrogen
(Scheme V), diminishing the abundances of the m/z 315
(from E1) and 317 (from E2) ions. With 4-OHE1-2-SG
and 4-OHE2-2-SG adducts, oxidation of the steroid is
difficult because the sulfur attachment site is now more
remote from the hydrogen sources. The proposed origin
of the oxidized-steroid ion [m/z 517 (E1) and 519 (E2)] is
consistent with the breakdown curves (Figure 3).
FAB-produced ions. FAB-produced [M1H]1 ions of
glutathione and of the isomeric conjugates were studied
by using HE CAD to learn about the fragmentation of
these ions under conditions in which the ions have
higher internal energy [23]. Product ions from backbone
fragmentation (type 1) become more pronounced be-
cause the proton can now attach to low proton-affinity
amide nitrogens. This makes FAB in combination with
HE CAD, the method of choice for obtaining sequence
information of peptides [24], although its sensitivity is
not high.
The fragmentation behavior of the unmodified GSH,
under high-energy conditions, is different from that
observed under LE CAD conditions. The ion of m/z 76
(y1), 84 (a1 2 H2O), 179 (y2) and 130 (b1) are more
abundant upon high-energy collisions. The z2 (of m/z
162) and b2 (of m/z 233) are less abundant than upon
low-energy activation. The HE CAD spectrum of ESI-
produced ions is similar to that of FAB-produced ions.
HE CAD spectra of FAB-produced E1 and E2-conju-
Figure 6. Tandem mass spectra of ESI-produced [M1H]1 ions
from (A) 4-OHE2-2-SG, (B) 2-OHE2-4-SG, and (C) 2-OHE2-1-SG,
obtained by using a tandem four-sector mass spectrometer.
Scheme IV. Proposed mechanism for the formation of ion of
m/z 315 (E1) and 317 (E2) from 2-OHE-1-SG conjugates.
Scheme V. Proposed mechanism for the formation of ion of m/z
315 (E1) and 317 (E2) from 2-OHE-4-SG conjugates.
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gate ions show clearly the trend established for ESI-
produced ions: the m/z 315 (from E1) and 317 (from E2)
ions and the water-loss products at m/z 297 and 299 are
absent, modest, and high abundance in the spectra of
4-OHE-2-SG, 2-OHE-4-SG, and 2-OHE-1-SG, respec-
tively. In addition, the low-mass region of the spectra
shows that more abundant backbone-cleavage (type 1)
product ions are formed.
Metastable-Ion Spectra
Ions with relatively higher internal energy than the
stable ions fragment during transit to the detector and
give metastable-ion spectra. Similar to the breakdown
graphs obtained using the triple quadrupole, MI spectra
give information on the lowest energy fragments, which
are usually first- and second-generation product ions.
The ions are less abundant than in CAD spectra, ex-
plaining the need for a magnification factor of 10 or 20
times greater than that used for CAD spectra.
A typical MI spectrum contains, as the most abun-
dant product ion, that of m/z 463, which is a *y2 ion
formed from the [M1H]1 ions, showing that this first-
generation ion is formed by the lowest energy process.
Other fragment ions at m/z 575 ([M1H 2 NH3]
1), 574
([M1H 2 H2O]
1), 173 (d2), and 130 (b1) have relative
abundances between 5% and 30%. These MI spectra
have little utility for structure determination.
Conclusions
A long-standing goal of our research has been to
develop an understanding of the fragmentation chem-
istry of carcinogen-DNA adducts to assist tumor-initi-
ation studies. Isomer distinction is important in reach-
ing our goal because some isomeric adducts depurinate,
some produce lesions, and others are harmless. Detecting
DNA modifications to estimate risk is difficult because
levels of modification are small. Therefore, we are expand-
ing our research to GSH conjugates, which, when bound
to estrogens, may be particularly important for estimating
risk for breast cancer.
Unambiguous identification of the spectra relies on
the type-4 ions of m/z 315 and 297 for E1 conjugates and
of m/z 317 and 299 for E2 conjugates. The formation of
these ions is most favored when the GSH attachment is
at position 1 of the steroid, but still occurs when the
attachment is at position 4. We picture these unusual
isomerically distinctive reactions as proceeding by oxi-
dation of the steroid moiety and reduction of the
departing neutral GSH. These trends are more obvious
in HE CAD and in ESI-source CAD spectra than in the
LE CAD spectra from ion-trap and triple-quadrupole
tandem instruments, although higher order MS/MS
experiments with the ion trap may produce the desired
information. Increasing the collision energy in the low-
energy regime increases the relative abundances of
these ions at the expense of high-mass ions. LE CAD
requires a tradeoff when choosing the collision energy,
and an uninformed choice without a reference com-
pound may give incomplete information.
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